Skip to main content

Advertisement

Erratum to: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells

Article metrics

The original article was published in BMC Cancer 2014 14:373

Erratum

Unfortunately, the original version of this article [1] contained an error within Fig. 5. For testing Sema4D protein expression in PaTu8988 cells with/out SAHA treatment, the protein samples of Fig. 2D were re-tested by Western blot assay using Sema4D antibody (Fig. 5E). The correct version of Fig. 5E can be found below. This does not alter the conclusion of the result.

Fig. 5
figure1

PaTu8988 cells were incubated with SAHA at indicated dosage for 48 hours, the protein expressions of Sema4D and tubulin were tested by Western blots. Experiments in this figure were repeated three times, and similar results were obtained. e SAHA suppresses PaTu8988 cell vasculogenic mimicry (VM)

References

  1. 1.

    Xu X, Yang L, Zheng L, Pan Y, Cao Z, Zhang Z, Zhou Q, et al. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells. BMC Cancer. 2014;14:373. doi:10.1186/1471-2407-14-373.

Download references

Author information

Correspondence to Bo Yang or Cong Cao.

Additional information

The online version of the original article can be found under doi:10.1186/1471-2407-14-373.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Xu, X., Yang, L., Zheng, L. et al. Erratum to: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells. BMC Cancer 16, 374 (2016) doi:10.1186/s12885-016-2401-3

Download citation